SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) Total liabilities 2024–2025
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) total liabilities at each fiscal year-end, per SEC filings.
$3.5MFY2025 · since FY2024: $3.5M → $3.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.5M | +1.5% |
| FY2024 | $3.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More SCNI financial trends
SCNI RevenueSCNI Net incomeSCNI Net marginSCNI Gross profitSCNI Gross marginSCNI Operating incomeSCNI Operating marginSCNI Operating cash flowSCNI Free cash flowSCNI Capital expendituresSCNI Return on equitySCNI Stock buybacksSCNI Dividends paidSCNI Total assetsSCNI Shareholders’ equitySCNI overview →